Citations

Clear

94 citation(s) found for "Raghunathan, Aditya".

Unique cause of right hemispheric syndrome: Embolism of myocardium after open septal myectomy
Murphy, Meghan E. , Raghunathan, Aditya , Schaff, Hartzell V. , Fugate, Jennifer E. , Schaff, Hartzell, Lanzino, Giuseppe , Raghunathan, Aditya , Schaff, Hartzell

Mayo Clinic

The Neuroradiology Journal | February 2, 2016 | Volume: 29 | Issue: 2 | Pages: 110-114

10.1177/1971400916628169 | PMID 26838173 Get It

We present a novel case of acute ischemic stroke in the postoperative setting of open septal myectomy. A 24-year-old woman developed acute left hemiparesis and rightward eye deviation the morning after surgery. She underwent emergent endovascular stoke therapy by mechanical embolectomy with successful retrieval of a fragment of myocardium that was obstructing the right middle cerebral artery. To our knowledge there has been no previous case described of a myocardial fragment causing a proximal intracranial artery occlusion with resulting ischemia and infarction.
Case-Based Review: meningioma
Fogh, Shannon , Barker, Fred G., Brastianos, Priscilla K. , Clarke, Jennifer , Oberndorfer, Stephan, Preusser, Matthias , Raghunathan, Aditya , Santagata, Sandro , Theodosopoulos, Philip V. , Fogh, Shannon E, Clarke, Jennifer L, Johnson, Derek R. , Kaufmann, Timothy J. , Santagata, Sandro , Raghunathan, Aditya , Preusser, Matthias

Mayo Clinic

Neuro-Oncology Practice | January 15, 2016 | Volume: 3 | Issue: 2 | Pages: 120-134

10.1093/nop/npv063 | PMID 31386096 Get It

AbstractMeningioma is by far the most common primary intracranial tumor in adults. Treatment of meningioma is complex due to a tremendous amount of variability in tumor behavior. Many patients are incidentally found to have tumors that will remain asymptomatic throughout their lives. It is important to identify these patients so that they can be spared from potentially morbid interventions. On the other end of the spectrum, high-grade meningiomas can behave very aggressively. When treatment is necessary, surgical resection is the cornerstone of meningioma therapy. Studies spanning decades have demonstrated that extent of resection correlates with prognosis. Radiation therapy, either in the form of external beam radiation therapy or stereotactic radiosurgery, represents another important therapeutic tool that can be used in place of or as a supplement to surgery. There are no chemotherapeutic agents of proven efficacy against meningioma, and chemotherapy treatment is generally reserved for patients who have exhausted surgical and radiotherapy options. Ongoing and future studies will help to answer unresolved questions such as the optimum use of radiation in resected WHO grade II meningiomas and the efficacy of additional chemotherapy agents.
Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation
Carlson, Matthew L. , Jacob, Jeffrey T. , Habermann, Elizabeth B. , Glasgow, Amy E. , Raghunathan, Aditya , Link, Michael J., Glasgow, Amy E. , Link, Michael J. , Habermann, Elizabeth , Raghunathan, Aditya , Glasgow, Amy E

Mayo Clinic

Journal of Neurosurgery | January 8, 2016 | Volume: 125 | Issue: 5 | Pages: 1120-1129

10.3171/2015.7.jns151056 | PMID 26745487 Get It

OBJECTIVE Malignant peripheral nerve sheath tumors (MPNSTs) of the eighth cranial nerve (CN) are exceedingly rare. To date the literature has focused on MPNSTs occurring after radiation therapy for presumed benign vestibular schwannomas (VSs), while MPNSTs arising without prior irradiation have received little attention. The objectives of the current study are to characterize the epidemiology, clinical presentation, disease course, and outcome using a large national cancer registry database and a systematic review of the English literature. Additionally, a previously unreported case is presented. METHODS The authors conducted an analysis of the Surveillance, Epidemiology, and End Results (SEER) database, a systematic review of the literature, and present a case report. Data from all patients identified in the SEER database with a diagnosis of MPNST involving the eighth CN, without a history of prior radiation, were analyzed. Additionally, all cases reported in the English literature between January 1980 and March 2015 were reviewed. Finally, 1 previously unreported case is presented. RESULTS The SEER registries identified 30 cases between 1992 and 2012. The average incidence was 0.017 per 1 million persons per year (range 0.000–0.0687 per year). The median age at diagnosis was 55 years, and 16 (53%) were women. Thirteen cases were diagnosed upon autopsy. Of the 17 cases diagnosed while alive, the median follow-up was 118 days, with 3 deaths (18%) observed. When compared with the incidence of benign VS, 1041 VSs present for every 1 MPNST arising from the eighth CN. Including a previously unreported case from the authors' center, a systematic review of the English literature yielded 24 reports. The median age at diagnosis was 44 years, 50% were women, and the median tumor size at diagnosis was 3 cm. Eleven patients (46%) reported isolated audiovestibular complaints typical for VS while 13 (54%) exhibited facial paresis or other signs of a more aggressive process. Treatment included microsurgery alone, microsurgery with adjuvant radiation, or microsurgery with chemoradiation. Sixty-one percent of patients receiving treatment experienced recurrence, 22% of which were diagnosed with drop metastases to the spine. Ultimately, 13 patients (54%) died of progressive disease at a median of 3 months following diagnosis. The ability to achieve gross-total resection was the only feature that was associated with improved disease-specific survival. CONCLUSIONS MPNSTs of the eighth CN are extremely rare and portend a poor prognosis. Nearly half of patients initially present with findings consistent with a benign VS, often making an early diagnosis challenging. In light of these data, early radiological and clinical follow-up should be considered in those who elect nonoperative treatment, particularly in patients with a short duration of symptoms or atypical presentation. These data also provide a baseline rate of malignancy that should be considered when estimating the risk of malignant transformation following stereotactic radiosurgery for VS.
Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease
Rammo, Richard , Rock, Adam , Transou, Andrea, Raghunathan, Aditya , Rock, Jack , Raghunathan, Aditya

Mayo Clinic

Journal of Neurosurgery | August 14, 2015 | Volume: 124 | Issue: 2 | Pages: 496-500

10.3171/2015.1.jns142260 | PMID 26274993 Get It

Meningiomas are common intracranial tumors categorized as Grades I–III per the current WHO guidelines. A small percentage of meningiomas are Grades II and III, which are likely to recur after initial treatment. Grade III meningiomas are considered to be malignant and warrant aggressive management. If surgery and radiation fail to produce lasting remission, effective treatment options for patients with progressive anaplastic meningiomas are elusive. The authors present the case of a patient with a meningioma that gradually progressed from Grade I to Grade III over 12 years despite repeated surgery and radiation therapy. The patient has been in remission for over 3 years following octreotide therapy.